Identification of biomarkers for COVID-19 associated secondary hemophagocytic lymphohistiocytosis.

Autor: Canny SP; Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA., Stanaway IB; Kidney Research Institute and Division of Nephrology, Department of Medicine, University of Washington, Seattle, WA., Holton SE; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA.; Center for Translational Immunology, Benaroya Research Institute, Seattle, WA., Mitchem M; Center for Translational Immunology, Benaroya Research Institute, Seattle, WA., O'Rourke AR; Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA., Pribitzer S; Center for Systems Immunology, Benaroya Research Institute, Seattle, WA., Baxter SK; Department of Pediatrics, University of Washington, Seattle, WA.; Sonoma Biotherapeutics, Seattle, WA., Wurfel MM; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA., Malhotra U; Department of Infectious Disease, Virginia Mason Medical Center, Seattle, WA.; Department of Medicine, Section of Infectious Diseases, University of Washington, Seattle, WA., Buckner JH; Center for Translational Immunology, Benaroya Research Institute, Seattle, WA.; Department of Immunology, University of Washington, Seattle, WA., Bhatraju PK; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA., Morrell ED; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA., Speake C; Center for Interventional Immunology, Benaroya Research Institute, Seattle, WA., Mikacenic C; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA.; Center for Translational Immunology, Benaroya Research Institute, Seattle, WA., Hamerman JA; Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA.; Department of Immunology, University of Washington, Seattle, WA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Aug 15. Date of Electronic Publication: 2024 Aug 15.

The transcriptional and phenotypic characteristics that define alveolar macrophage subsets in acute hypoxemic respiratory failure.

Autor: Morrell ED; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA. edmorrel@uw.edu., Holton SE; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA., Lawrance M; Translational Immunology, Benaroya Research Institute, Seattle, WA, USA., Orlov M; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, USA., Franklin Z; Translational Immunology, Benaroya Research Institute, Seattle, WA, USA., Mitchem MA; Translational Immunology, Benaroya Research Institute, Seattle, WA, USA., DeBerg H; Translational Immunology, Benaroya Research Institute, Seattle, WA, USA., Gersuk VH; Translational Immunology, Benaroya Research Institute, Seattle, WA, USA., Garay A; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA., Barnes E; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA., Liu T; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA., Peltan ID; Division of Pulmonary and Critical Care Medicine, Intermountain Health, Murray, UT, USA., Rogers A; Division of Pulmonary and Critical Care, Stanford University, Stanford, CA, USA., Ziegler S; Translational Immunology, Benaroya Research Institute, Seattle, WA, USA., Wurfel MM; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, WA, USA., Mikacenic C; Translational Immunology, Benaroya Research Institute, Seattle, WA, USA. cmikacenic@benaroyaresearch.org.

Publikováno v: Nature communications [Nat Commun] 2023 Nov 17; Vol. 14 (1), pp. 7443. Date of Electronic Publication: 2023 Nov 17.

Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.

Autor: Morrell ED; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington.; Hospital and Specialty Medicine, VA Puget Sound Health Care System, Seattle, Washington., Bhatraju PK; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Sathe NA; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Lawson J; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Mabrey L; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Holton SE; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Presnell SR; Translational Immunology, Benaroya Research Institute, Seattle, Washington., Wiedeman A; Translational Immunology, Benaroya Research Institute, Seattle, Washington., Acosta-Vega C; Translational Immunology, Benaroya Research Institute, Seattle, Washington., Mitchem MA; Translational Immunology, Benaroya Research Institute, Seattle, Washington., Liu T; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Chai XY; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Sahi S; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Brager C; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Orlov M; Hospital and Specialty Medicine, VA Puget Sound Health Care System, Seattle, Washington., Sakr SS; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Sader A; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Lum DM; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Koetje N; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Garay A; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Barnes E; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Cromer G; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Bray MK; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Pipavath S; Department of Radiology, University of Washington, Seattle, Washington., Fink SL; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Evans L; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Long SA; Translational Immunology, Benaroya Research Institute, Seattle, Washington., West TE; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Wurfel MM; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington., Mikacenic C; Translational Immunology, Benaroya Research Institute, Seattle, Washington.

Publikováno v: American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2022 Jul 01; Vol. 323 (1), pp. L14-L26. Date of Electronic Publication: 2022 May 24.

A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability.

Autor: Jadaliha M; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Gholamalamdari O; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Tang W; Laboratory of human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America., Zhang Y; Department of Bioengineering and Beckman Institute of Advanced Science and Technology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Petracovici A; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Hao Q; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Tariq A; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Kim TG; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Holton SE; Department of Bioengineering and Beckman Institute of Advanced Science and Technology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Singh DK; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Li XL; Regulatory RNAs and Cancer Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America., Freier SM; Ionis Pharmaceuticals Inc., Carlsbad, CA, United States of America., Ambs S; Laboratory of human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America., Bhargava R; Department of Bioengineering and Beckman Institute of Advanced Science and Technology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Lal A; Regulatory RNAs and Cancer Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America., Prasanth SG; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America., Ma J; Department of Bioengineering and Beckman Institute of Advanced Science and Technology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.; School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, United States of America., Prasanth KV; Department of Cell and Developmental Biology, Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, United States of America.

Publikováno v: PLoS genetics [PLoS Genet] 2018 Nov 29; Vol. 14 (11), pp. e1007802. Date of Electronic Publication: 2018 Nov 29 (Print Publication: 2018).

Attenuated total reflectance Fourier-transform infrared spectroscopic imaging for breast histopathology.

Autor: Walsh MJ; Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL., Kajdacsy-Balla A, Holton SE, Bhargava R

Publikováno v: Vibrational Spectroscopy [Vib Spectrosc] 2012 May 01; Vol. 60, pp. 23-28.